Last 12 months
Inside the activity.
1 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2023 Filed Apr 3, 2023 22:49 UTC |
ORLANDO STEVEN JDirector
|
GrantCommon Stock | 206 | $267.49 | $55,102.94 |
DisclosureSEC source: 0001179929-23-000059 · wf-form4_168056217638062.xml · nonDerivative · entry 1 ORLANDO STEVEN J · CIK 0001211493 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 20,805 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 31, 2023, of $267.49. Thus, the grant this quarter for services as a Director is for 206 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on March 31, 2023. F4 · ownership.nature: Shares are held by Orlando Family Trust. Read SEC document |
| April 01, 2023 Filed Apr 3, 2023 22:49 UTC |
ZORETIC RICHARD CDirector
|
GrantCommon Stock | 206 | $267.49 | $55,102.94 |
DisclosureSEC source: 0001179929-23-000058 · wf-form4_168056216059264.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 5,820 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 31, 2023, of $267.49. Thus, the grant this quarter for services as a Director is for 206 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on March 31, 2023. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| April 01, 2023 Filed Apr 3, 2023 22:49 UTC |
Russo MarcEVP, Health Plans
|
Tax withholdingCommon Stock | 2,179 | $267.49 | $582,860.71 |
DisclosureSEC source: 0001179929-23-000057 · wf-form4_168056214489076.xml · nonDerivative · entry 1 Russo Marc · CIK 0001504606 · EVP, Health Plans 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,616 F1 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 4,701 shares on April 1, 2023. F2 · price: Represents the closing price of the Issuer's common stock on March 31, 2023. F3 · balance_after: Shares shall vest as follows: 4,109 shares on March 1, 2024; 2,757 shares on March 1, 2025; and 1,582 shares on March 1, 2026. The remainder of the shares are vested. Read SEC document |
| April 01, 2023 Filed Apr 3, 2023 22:49 UTC |
COOPERMAN DANIELDirector
|
GrantCommon Stock | 206 | $267.49 | $55,102.94 |
DisclosureSEC source: 0001179929-23-000056 · wf-form4_168056212664020.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,150 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 31, 2023, of $267.49. Thus, the grant this quarter for services as a Director is for 206 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on March 31, 2023. Read SEC document |
| April 01, 2023 Filed Apr 3, 2023 22:48 UTC |
ROMNEY RONNADirector
|
GrantCommon Stock | 206 | $267.49 | $55,102.94 |
DisclosureSEC source: 0001179929-23-000055 · wf-form4_168056209944895.xml · nonDerivative · entry 1 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 16,891 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 31, 2023, of $267.49. Thus, the grant this quarter for services as a Director is for 206 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on March 31, 2023. F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| March 03, 2023 Filed Mar 3, 2023 23:24 UTC |
COOPERMAN DANIELDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001179929-23-000033 · wf-form4_167788586403203.xml · derivative · entry 3 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options are fully vested. Read SEC document |
| March 03, 2023 Filed Mar 3, 2023 23:24 UTC |
COOPERMAN DANIELDirector
|
SaleCommon Stock | 5,000 | $276.77 | $1,383,829.50 |
DisclosureSEC source: 0001179929-23-000033 · wf-form4_167788586403203.xml · nonDerivative · entry 2 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,944 F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $276.60 to $277.055. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2023 Filed Mar 3, 2023 23:24 UTC |
COOPERMAN DANIELDirector
|
Exercise / conversionCommon Stock | 5,000 | $33.02 | $165,100.00 |
DisclosureSEC source: 0001179929-23-000033 · wf-form4_167788586403203.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:27 UTC |
Russo MarcEVP, Health Plans
|
Tax withholdingCommon Stock | 19,609 | $273.80 | $5,368,944.20 |
DisclosureSEC source: 0001179929-23-000039 · wf-form4_167788602866971.xml · nonDerivative · entry 4 Russo Marc · CIK 0001504606 · EVP, Health Plans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,795 F5 · kind: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. F6 · balance_after: Shares shall vest as follows: the newly granted 4,748 shares vest in one-third increments on each of March 1, 2024, March 1, 2025, and March 1, 2026. Additional shares shall vest as follows: 2,526 shares on March 1, 2024; 1,175 shares on March 1, 2025; and 4,701 shares on April 1, 2023. The remainder of the shares are vested. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:27 UTC |
Russo MarcEVP, Health Plans
|
GrantCommon Stock | 42,314 | $273.80 | $11,585,573.20 |
DisclosureSEC source: 0001179929-23-000039 · wf-form4_167788602866971.xml · nonDerivative · entry 3 Russo Marc · CIK 0001504606 · EVP, Health Plans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,404 F4 · kind: Shares issued in settlement of performance stock units granted in 2020 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2020, 2021, and 2022. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:27 UTC |
Russo MarcEVP, Health Plans
|
GrantCommon Stock | 4,748 | $273.80 | $1,300,002.40 |
DisclosureSEC source: 0001179929-23-000039 · wf-form4_167788602866971.xml · nonDerivative · entry 2 Russo Marc · CIK 0001504606 · EVP, Health Plans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,090 F3 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:27 UTC |
Russo MarcEVP, Health Plans
|
Tax withholdingCommon Stock | 1,171 | $273.80 | $320,619.80 |
DisclosureSEC source: 0001179929-23-000039 · wf-form4_167788602866971.xml · nonDerivative · entry 1 Russo Marc · CIK 0001504606 · EVP, Health Plans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,342 F1 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 2,526 shares on March 1, 2023. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:27 UTC |
WOYS JAMESEVP, Health Plan Services
|
Tax withholdingCommon Stock | 7,707 | $273.80 | $2,110,176.60 |
DisclosureSEC source: 0001179929-23-000038 · wf-form4_167788600225919.xml · nonDerivative · entry 4 WOYS JAMES · CIK 0001213947 · EVP, Health Plan Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,354 F5 · kind: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. F6 · balance_after: Shares shall vest as follows: the 5,113 newly granted shares vest in one-third increments on each of March 1, 2023, March 1, 2024, and March 1, 2025. Additional shares shall vest as follows: 2,889 shares on March 1, 2024 and 1,389 shares on March 1, 2025. The remaining shares are vested. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:27 UTC |
WOYS JAMESEVP, Health Plan Services
|
GrantCommon Stock | 19,584 | $273.80 | $5,362,099.20 |
DisclosureSEC source: 0001179929-23-000038 · wf-form4_167788600225919.xml · nonDerivative · entry 3 WOYS JAMES · CIK 0001213947 · EVP, Health Plan Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,061 F4 · kind: Shares issued in settlement of performance stock units granted in 2020 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2020, 2021, and 2022. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:27 UTC |
WOYS JAMESEVP, Health Plan Services
|
GrantCommon Stock | 5,113 | $273.80 | $1,399,939.40 |
DisclosureSEC source: 0001179929-23-000038 · wf-form4_167788600225919.xml · nonDerivative · entry 2 WOYS JAMES · CIK 0001213947 · EVP, Health Plan Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,477 F3 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:27 UTC |
WOYS JAMESEVP, Health Plan Services
|
Tax withholdingCommon Stock | 1,446 | $273.80 | $395,914.80 |
DisclosureSEC source: 0001179929-23-000038 · wf-form4_167788600225919.xml · nonDerivative · entry 1 WOYS JAMES · CIK 0001213947 · EVP, Health Plan Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,364 F1 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 5,066 shares on March 1, 2023. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:26 UTC |
Zubretsky Joseph MDirector · President & CEO
|
Tax withholdingCommon Stock | 64,112 | $273.80 | $17,553,865.60 |
DisclosureSEC source: 0001179929-23-000037 · wf-form4_167788597108581.xml · nonDerivative · entry 4 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,516 F5 · kind: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. F6 · balance_after: Shares shall vest as follows: the 22,644 newly granted shares shall vest in one-third increments on each of March 1, 2024, March 1, 2025, and March 1, 2026. Additional shares shall vest as follows: 15,412 shares vest on March 1, 2024 and 6,412 shares vest on March 1, 2025. The remainder of the shares are vested. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:26 UTC |
Zubretsky Joseph MDirector · President & CEO
|
GrantCommon Stock | 134,638 | $273.80 | $36,863,884.40 |
DisclosureSEC source: 0001179929-23-000037 · wf-form4_167788597108581.xml · nonDerivative · entry 3 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,628 F4 · kind: Shares issued in settlement of performance stock units granted in 2020 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2020, 2021, and 2022. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:26 UTC |
Zubretsky Joseph MDirector · President & CEO
|
GrantCommon Stock | 22,644 | $273.08 | $6,183,623.52 |
DisclosureSEC source: 0001179929-23-000037 · wf-form4_167788597108581.xml · nonDerivative · entry 2 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,990 F3 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:26 UTC |
Zubretsky Joseph MDirector · President & CEO
|
Tax withholdingCommon Stock | 14,211 | $273.80 | $3,890,971.80 |
DisclosureSEC source: 0001179929-23-000037 · wf-form4_167788597108581.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,346 F1 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 30,372 shares on March 1, 2023. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:26 UTC |
HEBERT MAURICEChief Accounting Officer
|
Tax withholdingCommon Stock | 847 | $273.80 | $231,908.60 |
DisclosureSEC source: 0001179929-23-000036 · wf-form4_167788594820456.xml · nonDerivative · entry 4 HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,220 F5 · kind: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. F6 · balance_after: Shares shall vest as follows: the 730 newly granted shares shall vest in one-third increments on each of March 1, 2024, March 1, 2025, and March 1, 2026. Additional shares shall vest as follows: 1,032 shares vest on March 1, 2024 and 400 shares vest on March 1, 2025. The remainder of the shares are vested. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:26 UTC |
HEBERT MAURICEChief Accounting Officer
|
GrantCommon Stock | 2,652 | $273.80 | $726,117.60 |
DisclosureSEC source: 0001179929-23-000036 · wf-form4_167788594820456.xml · nonDerivative · entry 3 HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,067 F4 · kind: Shares issued in settlement of performance stock units granted in 2020 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2020, 2021, and 2022. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:26 UTC |
HEBERT MAURICEChief Accounting Officer
|
GrantCommon Stock | 730 | $273.80 | $199,874.00 |
DisclosureSEC source: 0001179929-23-000036 · wf-form4_167788594820456.xml · nonDerivative · entry 2 HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,415 F3 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:26 UTC |
HEBERT MAURICEChief Accounting Officer
|
Tax withholdingCommon Stock | 535 | $273.80 | $146,483.00 |
DisclosureSEC source: 0001179929-23-000036 · wf-form4_167788594820456.xml · nonDerivative · entry 1 HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,685 F1 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 1,303 shares on March 1, 2023. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:25 UTC |
Keim Mark LowellChief Financial Officer
|
Tax withholdingCommon Stock | 10,857 | $273.80 | $2,972,646.60 |
DisclosureSEC source: 0001179929-23-000035 · wf-form4_167788592159168.xml · nonDerivative · entry 4 Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,429 F5 · kind: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. F6 · balance_after: The shares shall vest as follows: the 5,844 newly granted shares shall vest in one-third increments on each of March 1, 2024, March 1, 2025, and March 1, 2026. Additional shares shall vest as follows: 3,703 on March 1, 2024 and 1,603 on March 1, 2025. The remaining shares are vested. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:25 UTC |
Keim Mark LowellChief Financial Officer
|
GrantCommon Stock | 24,480 | $273.08 | $6,684,998.40 |
DisclosureSEC source: 0001179929-23-000035 · wf-form4_167788592159168.xml · nonDerivative · entry 3 Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,286 F4 · kind: Shares issued in settlement of performance stock units granted in 2020 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2020, 2021, and 2022. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:25 UTC |
Keim Mark LowellChief Financial Officer
|
GrantCommon Stock | 5,844 | $273.08 | $1,595,879.52 |
DisclosureSEC source: 0001179929-23-000035 · wf-form4_167788592159168.xml · nonDerivative · entry 2 Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,806 F3 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:25 UTC |
Keim Mark LowellChief Financial Officer
|
Tax withholdingCommon Stock | 2,851 | $273.08 | $778,551.08 |
DisclosureSEC source: 0001179929-23-000035 · wf-form4_167788592159168.xml · nonDerivative · entry 1 Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,962 F1 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 6,424 shares on March 1, 2023. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:25 UTC |
Barlow Jeff D.Chief Legal Officer
|
Tax withholdingCommon Stock | 8,999 | $273.80 | $2,463,926.20 |
DisclosureSEC source: 0001179929-23-000034 · wf-form4_167788590226957.xml · nonDerivative · entry 4 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,398 F5 · kind: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. F6 · balance_after: Shares shall vest as follows: the 4,383 newly granted shares vest in one-third increments on each of March 1, 2024, March 1, 2025, and March 1, 2026. Additional shares shall vest as follows: 2,676 shares on March 1, 2024 and 1,175 shares on March 1, 2025. The remaining shares are vested. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:25 UTC |
Barlow Jeff D.Chief Legal Officer
|
GrantCommon Stock | 19,584 | $273.80 | $5,362,099.20 |
DisclosureSEC source: 0001179929-23-000034 · wf-form4_167788590226957.xml · nonDerivative · entry 3 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,397 F4 · kind: Shares issued in settlement of performance stock units granted in 2020 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2020, 2021, and 2022. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:25 UTC |
Barlow Jeff D.Chief Legal Officer
|
GrantCommon Stock | 4,383 | $273.80 | $1,200,065.40 |
DisclosureSEC source: 0001179929-23-000034 · wf-form4_167788590226957.xml · nonDerivative · entry 2 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,813 F3 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:25 UTC |
Barlow Jeff D.Chief Legal Officer
|
Tax withholdingCommon Stock | 3,700 | $273.80 | $1,013,060.00 |
DisclosureSEC source: 0001179929-23-000034 · wf-form4_167788590226957.xml · nonDerivative · entry 1 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,430 F1 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 8,048 shares on March 1, 2023. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2023. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 23:20 UTC |
BRASIER BARBARA LDirector
|
GrantCommon Stock | 167 | $330.22 | $55,146.74 |
DisclosureSEC source: 0001179929-23-000009 · wf-form4_167278800435702.xml · nonDerivative · entry 1 BRASIER BARBARA L · CIK 0001169490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,343 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 30, 2022, of $330.22. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 30, 2022. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 23:23 UTC |
WOLF DALE BDirector
|
GrantCommon Stock | 167 | $330.22 | $55,146.74 |
DisclosureSEC source: 0001179929-23-000015 · wf-form4_167278817270601.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,658 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 30, 2022, of $330.22. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 30, 2022. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 23:23 UTC |
Schapiro Richard MDirector
|
GrantCommon Stock | 167 | $330.22 | $55,146.74 |
DisclosureSEC source: 0001179929-23-000016 · wf-form4_167278819373380.xml · nonDerivative · entry 1 Schapiro Richard M · CIK 0001649773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,209 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 30, 2022, of $330.22. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 30, 2022. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 23:22 UTC |
Lockhart Stephen HDirector
|
GrantCommon Stock | 167 | $330.22 | $55,146.74 |
DisclosureSEC source: 0001179929-23-000014 · wf-form4_167278814773425.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,409 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 30, 2022, of $330.22. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 30, 2022. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 23:22 UTC |
COOPERMAN DANIELDirector
|
GrantCommon Stock | 167 | $330.22 | $55,146.74 |
DisclosureSEC source: 0001179929-23-000013 · wf-form4_167278811986106.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,944 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 30, 2022, of $330.22. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 30, 2022. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 23:21 UTC |
ZORETIC RICHARD CDirector
|
GrantCommon Stock | 167 | $330.22 | $55,146.74 |
DisclosureSEC source: 0001179929-23-000012 · wf-form4_167278808368311.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 5,614 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 30, 2022, of $330.22. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 30, 2022. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 23:21 UTC |
ROMNEY RONNADirector
|
GrantCommon Stock | 167 | $330.22 | $55,146.74 |
DisclosureSEC source: 0001179929-23-000011 · wf-form4_167278804267625.xml · nonDerivative · entry 1 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 16,685 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 30, 2022, of $330.22. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 30, 2022. F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 23:20 UTC |
ORLANDO STEVEN JDirector
|
GrantCommon Stock | 167 | $330.22 | $55,146.74 |
DisclosureSEC source: 0001179929-23-000010 · wf-form4_167278802267637.xml · nonDerivative · entry 1 ORLANDO STEVEN J · CIK 0001211493 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 20,599 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 30, 2022, of $330.22. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 30, 2022. F4 · ownership.nature: Shares are held by Orlando Family Trust. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 01:23 UTC |
Russo MarcEVP, Health Plans
|
SaleCommon Stock | 1,500 | $351.17 | $526,755.00 |
DisclosureSEC source: 0001179929-22-000186 · wf-form4_167098101208049.xml · nonDerivative · entry 1 Russo Marc · CIK 0001504606 · EVP, Health Plans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,513 F1 · price: Represents the actual selling price per share of all 1,500 shares. F2 · balance_after: Shares shall vest as follows: 2,526 shares on each of March 1, 2023 and March 1, 2024; 1,175 shares on March 1, 2025, and an additional 4,701 shares on April 1, 2023. The remainder of the shares are vested. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 00:59 UTC |
WOLF DALE BDirector
|
SaleCommon Stock | 50 | $341.30 | $17,065.00 |
DisclosureSEC source: 0001179929-22-000184 · wf-form4_167054751889276.xml · nonDerivative · entry 4 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,491 F4 · price: Represents the actual selling price per share of all 50 shares. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 00:59 UTC |
WOLF DALE BDirector
|
SaleCommon Stock | 347 | $340.75 | $118,240.25 |
DisclosureSEC source: 0001179929-22-000184 · wf-form4_167054751889276.xml · nonDerivative · entry 3 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,541 F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $340.25 to $341.23. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 00:59 UTC |
WOLF DALE BDirector
|
SaleCommon Stock | 1,253 | $339.54 | $425,443.62 |
DisclosureSEC source: 0001179929-22-000184 · wf-form4_167054751889276.xml · nonDerivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,888 F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $339.22 to $340.20. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 00:59 UTC |
WOLF DALE BDirector
|
SaleCommon Stock | 850 | $338.83 | $288,005.50 |
DisclosureSEC source: 0001179929-22-000184 · wf-form4_167054751889276.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,141 F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $338.22 to $339.20. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| November 29, 2022 Filed Dec 1, 2022 22:56 UTC |
Zubretsky Joseph MDirector · President & CEO
|
GiftCommon Stock | 4,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179929-22-000182 · wf-form4_166993537337088.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,557 F1 · kind: Reflects the gift of common stock to a charitable donor advised fund. F2 · price: Price not applicable to gift. F3 · balance_after: 30,372 shares vest on March 1, 2023; 15,412 shares vest on March 1, 2024; 6,412 shares vest on March 1, 2025. The remainder of the shares are vested. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 02:05 UTC |
WOLF DALE BDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $33.02 Strike: $33.02 | $198,120.00 |
DisclosureSEC source: 0001179929-22-000178 · wf-form4_166787312345320.xml · derivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options are fully vested. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 02:05 UTC |
WOLF DALE BDirector
|
Exercise / conversionCommon Stock | 6,000 | $33.02 | $198,120.00 |
DisclosureSEC source: 0001179929-22-000178 · wf-form4_166787312345320.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 02:05 UTC |
ROMNEY RONNADirector
|
SaleCommon Stock | 150 | $331.56 | $49,734.00 |
DisclosureSEC source: 0001179929-22-000177 · wf-form4_166787310269650.xml · nonDerivative · entry 1 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 16,518 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on March 8, 2022. F2 · price: Represents the actual selling price per share of all 150 shares. F3 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| October 31, 2022 Filed Oct 31, 2022 22:25 UTC |
Schapiro Richard MDirector
|
SaleCommon Stock | 200 | $355.69 | $71,138.00 |
DisclosureSEC source: 0001179929-22-000174 · wf-form4_166725510083582.xml · nonDerivative · entry 2 Schapiro Richard M · CIK 0001649773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,042 F2 · price: Represents the actual selling price per share of all 200 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.